nach oben

Erschienen in:

06.11.2023 | Herz-Kreislauf-Erkrankungen in der Gendermedizin | CME

Brustschmerz und kardiovaskuläre Erkrankungen bei Frauen

Diagnostik und Therapie

verfasst von: Dr. med. Janet-Jacqueline Olic, Prof. Dr. med. Andrea Baessler, Prof. Dr. med. Marcus Fischer

Erschienen in: Herz | Ausgabe 6/2023

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Kardiovaskuläre Erkrankungen (CVD) sind nicht nur bei Männern, sondern auch bei Frauen weltweit die führende Todesursache. Die Inzidenz für CVD nimmt bei Frauen insbesondere nach der Menopause deutlich zu. Die geschlechtsspezifischen Unterschiede in Inzidenz, Prävalenz und Mortalität von CVD sind auf hormonelle, anatomische sowie soziokulturelle Unterschiede zurückzuführen. Im Rahmen der Primär- und Sekundärprävention einer koronaren Herzkrankheit (KHK) sollten neben den klassischen kardiovaskulären Risikofaktoren auch frauenspezifische Risikofaktoren wie Autoimmunerkrankungen und schwangerschaftsassoziierte Erkrankungen (z. B. Gestationsdiabetes und Präeklampsie) Berücksichtigung finden. Ferner sollte bei Frauen mit Angina pectoris bedacht werden, dass insbesondere Frauen gehäuft an einer Ischämie mit nichtobstruktiven Koronararterien (INOCA) leiden, die beispielsweise durch eine mikrovaskuläre Dysfunktion (CMD) oder Koronarspasmen hervorgerufen werden kann. Basierend hierauf, sollte bei symptomatischen Frauen die Diagnostik nach einer Koronarangiographie mit unauffälligen epikardialen Gefäßen nicht beendet werden. Es sollte frühzeitig eine gezielte Diagnostik bezüglich CMD und Koronarspasmen erfolgen.

Roth GA, Mensah GA, Johnson CO et al (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010CrossRefPubMedPubMedCentral

Timmis A, Vardas P, Townsend N et al (2022) European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J 43(8):716–799. https://doi.org/10.1093/eurheartj/ehab892CrossRefPubMed

(2021) 33. Deutscher. Herzbericht, Bd. 2021. Deutsche Herzstiftung e.V, Frankfurt

Maas AHEM, Appelman YEA (2010) Gender differences in coronary heart disease. Neth Heart J 18(12):598–602. https://doi.org/10.1007/s12471-010-0841-yCrossRefPubMedPubMedCentral

Haider A, Bengs S, Luu J et al (2020) Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J 41(13):1328–1336. https://doi.org/10.1093/eurheartj/ehz898CrossRefPubMed

Vaccarino V (2019) Myocardial Infarction in Young Women. Circulation 139(8):1057–1059. https://doi.org/10.1161/CIRCULATIONAHA.118.039298CrossRefPubMedPubMedCentral

Arora S, Stouffer GA, Kucharska-Newton AM et al (2019) Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction. Circulation 139(8):1047–1056. https://doi.org/10.1161/CIRCULATIONAHA.118.037137CrossRefPubMedPubMedCentral

Gabet A, Danchin N, Juillière Y, Olié V (2017) Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004–14. Eur Heart J 38(14):1060–1065. https://doi.org/10.1093/eurheartj/ehx097CrossRefPubMed

Smilowitz NR, Gupta N, Guo Y et al (2018) Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States. Mayo Clin Proc 93(10):1404–1414. https://doi.org/10.1016/j.mayocp.2018.04.019CrossRefPubMed

10.

Xi Z, Qiu H, Guo T et al (2022) Contemporary sex differences in mortality among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis. Bmj Open 12(3):e53379. https://doi.org/10.1136/bmjopen-2021-053379CrossRefPubMedPubMedCentral

11.

Peterson KA, Kaur G, Gianos E et al (2022) Challenges in Optimizing Lipid Management in Women. Cardiovasc Drugs Ther 36(6):1197–1220. https://doi.org/10.1007/s10557-021-07273-0CrossRefPubMed

12.

Matthews KA, Crawford SL, Chae CU et al (2009) Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 54(25):2366–2373. https://doi.org/10.1016/j.jacc.2009.10.009CrossRefPubMedPubMedCentral

13.

Kander MC, Cui Y, Liu Z (2017) Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med 21(5):1024–1032. https://doi.org/10.1111/jcmm.13038CrossRefPubMed

14.

Du Xiang LY, Zhou S et al (2021) Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress. Oxid Med Cell Longev 2021:5523516. https://doi.org/10.1155/2021/5523516CrossRefPubMedPubMedCentral

15.

Somani YB, Pawelczyk JA, de Souza MJ et al (2019) Aging women and their endothelium: probing the relative role of estrogen on vasodilator function. Am J Physiol Heart Circ Physiol 317(2):H395–H404. https://doi.org/10.1152/ajpheart.00430.2018CrossRefPubMedPubMedCentral

16.

Xue B, Johnson AK, Hay M (2013) Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. Am J Physiol Regul Integr Comp Physiol 305(5):R459–63. https://doi.org/10.1152/ajpregu.00222.2013CrossRefPubMedPubMedCentral

17.

Beale AL, Meyer P, Marwick TH et al (2018) Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction. Circulation 138(2):198–205. https://doi.org/10.1161/CIRCULATIONAHA.118.034271CrossRefPubMed

18.

Hiteshi AK, Li D, Gao Y et al (2014) Gender differences in coronary artery diameter are not related to body habitus or left ventricular mass. Clin Cardiol 37(10):605–609. https://doi.org/10.1002/clc.22310CrossRefPubMedPubMedCentral

19.

Patel MB, Bui LP, Kirkeeide RL, Gould KL (2016) Imaging Microvascular Dysfunction and Mechanisms for Female-Male Differences in CAD. JACC Cardiovasc Imaging 9(4):465–482. https://doi.org/10.1016/j.jcmg.2016.02.003CrossRefPubMed

20.

Davies PF (1995) Flow-mediated endothelial mechanotransduction. Physiol Rev 75(3):519–560. https://doi.org/10.1152/physrev.1995.75.3.519CrossRefPubMed

21.

Davies PF (2009) Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med 6(1):16–26. https://doi.org/10.1038/ncpcardio1397CrossRefPubMed

22.

Beyer AM, Durand MJ, Hockenberry J et al (2014) An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles. Am J Physiol Heart Circ Physiol 307(11):H1587–93. https://doi.org/10.1152/ajpheart.00557.2014CrossRefPubMedPubMedCentral

23.

Paniagua OA, Bryant MB, Panza JA (2001) Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 103(13):1752–1758. https://doi.org/10.1161/01.cir.103.13.1752CrossRefPubMed

24.

Reynolds HR, Shaw LJ, Min JK et al (2020) Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol 5(7):773–786. https://doi.org/10.1001/jamacardio.2020.0822CrossRefPubMed

25.

Kunadian V, Chieffo A, Camici PG et al (2020) An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 41(37):3504–3520. https://doi.org/10.1093/eurheartj/ehaa503CrossRefPubMedPubMedCentral

26.

Stangl V, Lueg J (2022) Kardiale Erkrankungen bei Frauen. In: Marx N, Erdmann E (Hrsg) Klinische Kardiologie: Krankheiten des Herzens, des Kreislaufs und der herznahen Gefäße. Springer, Berlin, Heidelberg, S 1–29

27.

Pepine CJ, Anderson RD, Sharaf BL et al (2010) Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 55(25):2825–2832. https://doi.org/10.1016/j.jacc.2010.01.054CrossRefPubMedPubMedCentral

28.

Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E et al (2016) Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J 37(1):24–34. https://doi.org/10.1093/eurheartj/ehv598CrossRefPubMed

29.

Mehilli J, Presbitero P (2020) Coronary artery disease and acute coronary syndrome in women. Heart 106(7):487–492. https://doi.org/10.1136/heartjnl-2019-315555CrossRefPubMed

30.

Eskerud I, Gerdts E, Nordrehaug JE, Lønnebakken MT (2015) Global coronary artery plaque area is associated with myocardial hypoperfusion in women with non-ST elevation myocardial infarction. J Womens Health 24(5):367–373. https://doi.org/10.1089/jwh.2014.4920CrossRef

31.

Saw J, Aymong E, Sedlak T, Buller CE et al (2014) Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardiovasc Interv 7(5):645–655. https://doi.org/10.1161/CIRCINTERVENTIONS.114.001760CrossRefPubMed

32.

Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. https://doi.org/10.1093/eurheartj/ehad191CrossRefPubMed

33.

Sharkey SW, Maron BJ (2014) Epidemiology and clinical profile of Takotsubo cardiomyopathy. Circ J 78(9):2119–2128. https://doi.org/10.1253/circj.cj-14-0770CrossRefPubMed

34.

Komamura K, Fukui M, Iwasaku T et al (2014) Takotsubo cardiomyopathy: pathophysiology, diagnosis and treatment. World J Cardiol 6(7):602–609. https://doi.org/10.4330/wjc.v6.i7.602CrossRefPubMedPubMedCentral

35.

Pope JH, Aufderheide TP, Ruthazer R et al (2000) Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 342(16):1163–1170. https://doi.org/10.1056/NEJM200004203421603CrossRefPubMed

36.

Trutter L, Bigeh A, Pecci C et al (2020) Diagnostic and management dilemmas in women presenting with acute coronary syndromes. Curr Cardiol Rep 22(12):163. https://doi.org/10.1007/s11886-020-01410-1CrossRefPubMed

37.

Wagner GS, Macfarlane P, Wellens H et al (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 119(10):e262–e270. https://doi.org/10.1161/CIRCULATIONAHA.108.191098CrossRefPubMed

38.

Shah ASV, Griffiths M, Lee KK et al (2015) High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 350:g7873. https://doi.org/10.1136/bmj.g7873CrossRefPubMedPubMedCentral

39.

Mieres JH, Shaw LJ, Arai A et al (2005) Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention. Am Heart Assoc Circ 111(5):682–696. https://doi.org/10.1161/01.CIR.0000155233.67287.60CrossRef

40.

Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41(3):407–477. https://doi.org/10.1093/eurheartj/ehz425CrossRefPubMed

41.

Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003. https://doi.org/10.1093/eurheartj/eht296CrossRefPubMed

42.

Norris CM, Yip CYY, Nerenberg KA et al (2020) State of the science in women’s cardiovascular disease: a Canadian perspective on the influence of sex and gender. J Am Heart Assoc 9(4):e15634. https://doi.org/10.1161/JAHA.119.015634CrossRefPubMedPubMedCentral

43.

Sliwicka O, Sechopoulos I, Baggiano A et al (2023) Dynamic myocardial CT perfusion imaging-state of the art. Eur Radiol 33(8):5509–5525. https://doi.org/10.1007/s00330-023-09550-yCrossRefPubMedPubMedCentral

44.

Ahmadi A, Stone GW, Leipsic J et al (2016) Association of coronary stenosis and plaque morphology with fractional flow reserve and outcomes. JAMA Cardiol 1(3):350–357. https://doi.org/10.1001/jamacardio.2016.0263CrossRefPubMed

45.

Shaw LJ, Merz CNB, Pepine CJ et al (2006) The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health—National Heart, Lung, and Blood Institute—sponsored Women’s Ischemia Syndrome Evaluation. Circulation 114(9):894–904. https://doi.org/10.1161/CIRCULATIONAHA.105.609990CrossRefPubMed

46.

Aziz A, Hansen HS, Sechtem U et al (2017) Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries. J Am Coll Cardiol 70(19):2349–2358. https://doi.org/10.1016/j.jacc.2017.09.016CrossRefPubMed

47.

Garcia M, Mulvagh SL, Merz CNB et al (2016) Cardiovascular disease in women: clinical perspectives. Circ Res 118(8):1273–1293. https://doi.org/10.1161/CIRCRESAHA.116.307547CrossRefPubMedPubMedCentral

48.

Mehta LS, Beckie TM, DeVon HA et al (2016) Acute myocardial infarction in women: a scientific statement from the American heart association. Circulation 133(9):916–947. https://doi.org/10.1161/CIR.0000000000000351CrossRefPubMed

49.

O’Donoghue M, Boden WE, Braunwald E et al (2008) Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 300(1):71–80. https://doi.org/10.1001/jama.300.1.71CrossRefPubMed

50.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J et al (2019) 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Kardiol Pol 77(3):245–326. https://doi.org/10.5603/KP.2019.0049CrossRefPubMed

51.

Waheed N, Elias-Smale S, Malas W et al (2020) Sex differences in non-obstructive coronary artery disease. Cardiovasc Res 116(4):829–840. https://doi.org/10.1093/cvr/cvaa001CrossRefPubMed

52.

Dessy C, Saliez J, Ghisdal P et al (2005) Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. Circulation 112(8):1198–1205. https://doi.org/10.1161/CIRCULATIONAHA.104.532960CrossRefPubMed

53.

Fongemie J, Felix-Getzik E (2015) A review of nebivolol pharmacology and clinical evidence. Drugs 75(12):1349–1371. https://doi.org/10.1007/s40265-015-0435-5CrossRefPubMedPubMedCentral

54.

Kayaalti F, Kalay N, Basar E et al (2010) Effects of nebivolol therapy on endothelial functions in cardiac syndrome X. Heart Vessels 25(2):92–96. https://doi.org/10.1007/s00380-009-1170-1CrossRefPubMed

55.

Fatahian A (2019) Nebivolol for improving endothelial dysfunction in cardiac syndrome‑x; Is it ready for clinical use? ARYA Atheroscler 15(6):292–293. https://doi.org/10.22122/arya.v15i6.1971CrossRefPubMedPubMedCentral

56.

Cho L, Davis M, Elgendy I et al (2020) Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. J Am Coll Cardiol 75(20):2602–2618. https://doi.org/10.1016/j.jacc.2020.03.060CrossRefPubMedPubMedCentral

57.

Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42(34):3227–3337. https://doi.org/10.1093/eurheartj/ehab484CrossRefPubMed

58.

Fulcher J, O’Connell R, Voysey M et al (2015) Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 385(9976):1397–1405. https://doi.org/10.1016/S0140-6736(14)61368-4CrossRefPubMed

59.

Peters SAE, Huxley RR, Woodward M (2014) Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 57(8):1542–1551. https://doi.org/10.1007/s00125-014-3260-6CrossRefPubMed

60.

Savji N, Meijers WC, Bartz TM et al (2018) The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail 6(8):701–709. https://doi.org/10.1016/j.jchf.2018.05.018CrossRefPubMedPubMedCentral

61.

Wilson PWF, D’Agostino RB, Sullivan L et al (2002) Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162(16):1867–1872. https://doi.org/10.1001/archinte.162.16.1867CrossRefPubMed

62.

Vasan RS, Larson MG, Leip EP et al (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345(18):1291–1297. https://doi.org/10.1056/NEJMoa003417CrossRefPubMed

63.

Njølstad I, Arnesen E, Lund-Larsen PG (1996) Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 93(3):450–456. https://doi.org/10.1161/01.cir.93.3.450CrossRefPubMed

64.

Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378(9799):1297–1305. https://doi.org/10.1016/S0140-6736(11)60781-2CrossRefPubMed

65.

Geraghty L, Figtree GA, Schutte AE et al (2021) Cardiovascular disease in women: from pathophysiology to novel and emerging risk factors. Heart Lung Circ 30(1):9–17. https://doi.org/10.1016/j.hlc.2020.05.108CrossRefPubMed

66.

Ellins EA, Harris DE, Lacey A et al (2022) Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex. PLoS ONE 17(2):e264529. https://doi.org/10.1371/journal.pone.0264529CrossRefPubMedPubMedCentral

67.

Russo G, Pintaudi B, Giorda C et al (2015) Age- and gender-related differences in LDL-cholesterol management in outpatients with type 2 diabetes mellitus. Int J Endocrinol 2015:957105. https://doi.org/10.1155/2015/957105CrossRefPubMedPubMedCentral

68.

Schoen MW, Tabak RG, Salas J et al (2016) Comparison of adherence to guideline-based cholesterol treatment goals in men versus women. Am J Cardiol 117(1):48–53. https://doi.org/10.1016/j.amjcard.2015.10.007CrossRefPubMed

69.

Vogel B, Acevedo M, Appelman Y et al (2021) The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 397(10292):2385–2438. https://doi.org/10.1016/S0140-6736(21)00684-XCrossRefPubMed

70.

Zhao L, Zhu Z, Lou H et al (2016) Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget 7(23):33715–33721. https://doi.org/10.18632/oncotarget.9553CrossRefPubMedPubMedCentral

71.

Teede HJ, Misso ML, Costello MF et al (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol 89(3):251–268. https://doi.org/10.1111/cen.13795CrossRef

72.

Mehta LS (2011) Cardiovascular disease and depression in women. Heart Fail Clin 7(1):39–45. https://doi.org/10.1016/j.hfc.2010.08.005CrossRefPubMed

73.

Vaccarino V, Sullivan S, Hammadah M et al (2018) Mental stress-induced-myocardial Ischemia in young patients with recent myocardial infarction: sex differences and mechanisms. Circulation 137(8):794–805. https://doi.org/10.1161/CIRCULATIONAHA.117.030849CrossRefPubMedPubMedCentral

74.

Vaccarino V, Wilmot K, Al Mheid I et al (2016) Sex differences in mental stress-induced myocardial Ischemia in patients with coronary heart disease. J Am Heart Assoc. https://doi.org/10.1161/JAHA.116.003630CrossRefPubMedPubMedCentral

Titel: Brustschmerz und kardiovaskuläre Erkrankungen bei Frauen
Diagnostik und Therapie
verfasst von: Dr. med. Janet-Jacqueline Olic
Prof. Dr. med. Andrea Baessler
Prof. Dr. med. Marcus Fischer
Publikationsdatum: 06.11.2023
Verlag: Springer Medizin
Schlagwörter: Herz-Kreislauf-Erkrankungen in der Gendermedizin
Akutes Koronarsyndrom
Klimakterium und Menopause
Instabile Angina pectoris
Koronare Herzerkrankung
Herz-Kreislauf-Erkrankungen in der Hausarztpraxis
Erschienen in: Herz / Ausgabe 6/2023
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-023-05215-0

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2023

A mix of aminophylline and heparin plus nitroglycerin can reduce bradycardia during rotational atherectomy on the right coronary artery and dominant circumflex artery

Healthcare provision of transcatheter aortic valve implantation in Germany

Real-world evidence for the use of subcutaneous implantable cardioverter–defibrillators in China: A single-center experience

Prähospitale Reanimationen

Kardiologische Versorgungsforschung

T-TEER: Beschreibung eines Entwicklungsprozesses